Marshall Wace’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $118M | Buy |
1,253,138
+180,647
| +17% | +$18M | 0.12% | 136 |
|
|
2025
Q4 | $106M | Buy |
1,072,491
+1,056,451
| +6,586% | +$102M | 0.1% | 160 |
|
|
2025
Q3 | $1.36M | Sell |
16,040
-1,195,191
| -99% | -$94.5M | ﹤0.01% | 1803 |
|
|
2025
Q2 | $82.5M | Buy |
+1,211,231
| New | +$76.7M | 0.09% | 206 |
|
|
2025
Q1 | – | Sell |
-585,718
| Closed | -$40.5M | – | 2844 |
|
|
2024
Q4 | $40.5M | Sell |
585,718
-692,592
| -54% | -$49.4M | 0.05% | 330 |
|
|
2024
Q3 | $84.5M | Buy |
1,278,310
+1,244,768
| +3,711% | +$79.4M | 0.1% | 173 |
|
|
2024
Q2 | $2.03M | Sell |
33,542
-258,159
| -89% | -$14.6M | ﹤0.01% | 1365 |
|
|
2024
Q1 | $16.6M | Buy |
291,701
+249,042
| +584% | +$14.9M | 0.03% | 579 |
|
|
2023
Q4 | $2.68M | Sell |
42,659
-546,865
| -93% | -$30.9M | ﹤0.01% | 1106 |
|
|
2023
Q3 | $34.1M | Buy |
589,524
+444,439
| +306% | +$28M | 0.07% | 290 |
|
|
2023
Q2 | $9.03M | Sell |
145,085
-38,005
| -21% | -$2.54M | 0.02% | 781 |
|
|
2023
Q1 | $13.2M | Sell |
183,090
-83,722
| -31% | -$6.55M | 0.03% | 604 |
|
|
2022
Q4 | $21.4M | Buy |
266,812
+219,012
| +458% | +$16.8M | 0.05% | 430 |
|
|
2022
Q3 | $3.19M | Buy |
+47,800
| New | +$3.53M | 0.01% | 1706 |
|
|
2022
Q1 | – | Sell |
-408,989
| Closed | -$30M | – | 3645 |
|
|
2021
Q4 | $30M | Buy |
408,989
+365,425
| +839% | +$24.6M | 0.06% | 352 |
|
|
2021
Q3 | $3M | Buy |
43,564
+30,850
| +243% | +$2.34M | 0.01% | 1261 |
|
|
2021
Q2 | $1.07M | Sell |
12,714
-82,440
| -87% | -$6.87M | ﹤0.01% | 1776 |
|
|
2021
Q1 | $7.73M | Buy |
+95,154
| New | +$8.12M | 0.04% | 584 |
|
|
2020
Q2 | – | Sell |
-65
| Closed | -$5K | – | 1744 |
|
|
2020
Q1 | $5K | Sell |
65
-32,176
| -100% | -$2.43M | ﹤0.01% | 1567 |
|
|
2019
Q4 | $2.81M | Sell |
32,241
-61,470
| -66% | -$5.25M | 0.02% | 712 |
|
|
2019
Q3 | $6.96M | Buy |
93,711
+66,132
| +240% | +$5.34M | 0.05% | 397 |
|
|
2019
Q2 | $2.34M | Buy |
27,579
+11,316
| +70% | +$908K | 0.02% | 728 |
|
|
2019
Q1 | $1.4M | Buy |
+16,263
| New | +$1.32M | 0.01% | 842 |
|
|
2018
Q4 | – | Sell |
-36,209
| Closed | -$2.5M | – | 1686 |
|
|
2018
Q3 | $2.5M | Buy |
+36,209
| New | +$2.49M | 0.02% | 620 |
|
|
2017
Q2 | – | Sell |
-14,916
| Closed | -$2M | – | 351 |
|
|
2017
Q1 | $2M | Sell |
14,916
-925,387
| -98% | -$118M | 0.1% | 136 |
|
|
2016
Q4 | $94.3M | Buy |
940,303
+196,129
| +26% | +$19.1M | 0.62% | 28 |
|
|
2016
Q3 | $70.2M | Buy |
744,174
+106,511
| +17% | +$8.97M | 0.5% | 44 |
|
|
2016
Q2 | $51M | Buy |
637,663
+440,877
| +224% | +$34.2M | 0.43% | 48 |
|
|
2016
Q1 | $14.3M | Buy |
196,786
+183,209
| +1,349% | +$13.7M | 0.14% | 159 |
|
|
2015
Q4 | $1.47M | Sell |
13,577
-76,715
| -85% | -$8.56M | 0.01% | 615 |
|
|
2015
Q3 | $9.96M | Sell |
90,292
-17,183
| -16% | -$1.93M | 0.12% | 177 |
|
|
2015
Q2 | $11.2M | Buy |
107,475
+19,460
| +22% | +$2.01M | 0.15% | 160 |
|
|
2015
Q1 | $8.07M | Buy |
+88,015
| New | +$7.28M | 0.11% | 231 |
|
|
2014
Q3 | – | Sell |
-33,118
| Closed | -$1.87M | – | 950 |
|
|
2014
Q2 | $1.87M | Buy |
+33,118
| New | +$1.69M | 0.03% | 411 |
|
Other funds holding INCY
BBA
VCM
VPM
Marshall Wace's INCY Position: Q1 2026 in Review
Marshall Wace increased its Incyte (INCY) stake by 17% in Q1 2026, buying an estimated $18M and bringing the position to 1,253,138 shares worth $118M. The position accounts for 0.12% of the portfolio, ranked #136.
Marshall Wace first reported a position in INCY in Q2 2014 and has held it in 34 quarters since. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.
- Marshall Wace held 1,253,138 shares of Incyte worth $118M as of Q1 2026.
- Marshall Wace bought 180,647 Incyte shares in Q1 2026, an estimated $18M.
- Incyte made up 0.12% of Marshall Wace's portfolio in Q1 2026, its #136 holding.
- Marshall Wace first reported a position in Incyte in Q2 2014 and has held it in 34 quarters since.
- 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.